|Articles|August 2, 2003
- Pharmaceutical Technology-08-02-2003
- Volume 27
- Issue 8
New FDA Initiatives Aim to Spur Innovation
Author(s)Jill Wechsler
Manufacturers face challenges from FDA's plans to streamline the drug review and development processes aimed to spur innovation.
Advertisement
Articles in this issue
over 22 years ago
BIO Updateover 22 years ago
Designing Transfer Carts for Class 100 Conditionsover 22 years ago
An Update on Osmotic Drug Deliveryover 22 years ago
Interphex Serves as a Showcase for New Materials and Machinesover 22 years ago
August 2003over 22 years ago
In the Spotlight August 2003Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
3
New Targets for Clinical Trials in the European Union
4
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
5
